US 12122843
High affinity monoclonal antibodies targeting glypican-1 and methods of use
granted A61KA61K2039/505A61K2039/852
Quick answer
US patent 12122843 (High affinity monoclonal antibodies targeting glypican-1 and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K2039/505, A61K2039/852, A61K47/6829, A61K47/6929